| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.3 | 1e-07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |